Salim Ismail Announced as Keynote Speaker at Mitratech's Interact 2018 Conference
Best-Selling Author and Tech Strategist Shares Insights on New Paradigm in Organizational Design
AUSTIN, Texas, July 18, 2018 (GLOBE NEWSWIRE) -- Mitratech , the leading provider of legal and compliance software solutions, today announced that Salim Ismail, best-selling author, founding executive director of Singularity University, and founder of ExO Works, will deliver the keynote address at its Interact 2018 Conference.
Every year the Interact conference provides an opportunity for clients, industry experts and partners to connect, learn, and contribute to insightful sessions on Mitratech innovations, legal operations best practices and industry trends. This year's theme, The Next Frontier of Legal Ops, recognizes that legal operations should be a center of innovation and excellence that brings people, processes and information together like never before by extending legal operations capabilities across the entire enterprise.
"Salim understands the power of innovation and technology to transform not only our organizations, but our understanding of what is possible," said Mitratech CEO Jason Parkman. "He will explore how we can bring new ideas and new approaches to our daily work, so that we can drive change and innovation by fostering creativity and empowering teams. We hope attendees come away from the conference with new perspectives and a more expansive view of what they can accomplish and the impact that they and their businesses can have. I find his work inspiring; I hope our clients do too."
Salim Ismail is the best-selling author of Exponential Organizations , a sought-after technology strategist, and a renowned entrepreneur with ties to Yahoo!, Google and Singularity University. He consults with governments and the world's top FORTUNE 500 companies on innovation and growth, and his work has been featured in premier media outlets like the New York Times, Bloomberg BusinessWeek, FORTUNE, Forbes, WIRED, Vogue, and the BBC.
The 2018 Interact conference will take place September 24-27 in Austin, Texas. To learn more about and register for the event visit https://interact.mitratech.com/ .
Mitratech is a proven global technology partner for corporate legal professionals who seek out and maximize opportunities to raise productivity, control expense, and mitigate risk by deepening organizational alignment, increasing visibility, and spurring collaboration across the enterprise. Serving 1,200 organizations of all sizes across the globe, we represent almost 40% of the Fortune 500 and over 500,000 users in over 160 countries.
With Mitratech's proven portfolio of end-to-end solutions, operational best practices spread throughout the enterprise, standardizing processes and accelerating time-to-value. By unlocking every opportunity to drive progress and improve outcomes, Mitratech is helping legal teams rise to the challenge of serving the evolving needs of the modern, dynamic enterprise.
For more info, visit: www.mitratech.com
MEDIA CONTACT: Sue Huss Mitratech email@example.com
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
DoubleVerify11.12.2018 18:05 | Pressemeddelelse
DoubleVerify and InMobi Unite to Combat Mobile App Fraud
Claroty11.12.2018 15:03 | Pressemeddelelse
Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform
Farmako GmbH11.12.2018 10:01 | Pressemeddelelse
Farmako: Cannabis distributor to become gateway to Europe
Graduate Management Admission Council10.12.2018 16:28 | Pressemeddelelse
The Graduate Management Admission Council Selects Three New Business Schools for Membership
CereSpir Inc.10.12.2018 15:01 | Pressemeddelelse
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
Centrient Pharmaceuticals10.12.2018 13:31 | Pressemeddelelse
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum